SYNH News and Press, Syneos Health Inc. From 02/08/23

MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year 2022 financial results on Thursday, February 16, 2023, prior to its earnings call at 8:00 ...

Syneos Health ( NASDAQ: SYNH ) announced a strategic partnership with Equicare to use proXimity, a cloud-based software platform that accelerates the transfer of clinical trial subject data from multiple electronic health records (or EHR) to the sponsor’s electronic data captur...

MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Equicare to use proXimity™, an innovative cloud-based software platform that acceler...

Syneos Health ( NASDAQ: SYNH ) is collaborating with Haystack Health to improve the identification and enrollment of patients for clinical trials using artificial intelligence (AI). Haystack is a Roivant Health portfolio company which develops AI and Natural Language Processing (NLP) ...

MORRISVILLE, N.C., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelli...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Mid Cap Growth Strategy targets attractively pr...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Higher interest rates created a difficult year for ...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Mid Cap Strategy applies quantitative and funda...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The pro-cyclical tilt of our portfolio helped the S...

Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies PR Newswire Partnership to Provide Cell and Gene Industry Integrated ...